Fund Holdings — Indaba Capital Management, L.P.

Total Portfolio Value
$233.71M
Total Bought
$41.15M
Total Sold
$14.15M
Net Transaction
+$27.00M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
EQUITY COMWLTH2,700,0004,700,000+2,000,00052,38093,53040.02%+41,150
ESPERION THERAPEUTICS INC NE00092632,01913.70%+31,092
IRONWOOD PHARMACEUTICALS INC(IRWD)00007,9613.41%+7,961
STANDARD BIOTOOLS INC00007,6323.27%+7,632
XOMETRY INC(XMTR)00013,37118,5517.94%+5,180
SUMMIT HOTEL PPTYS(INN)00004,2481.82%+4,248
ACCELERATE DIAGNOSTICS INC00011,60412,4105.31%+807
ON24 INC
COM
4,240,2564,240,256025,48425,95011.10%+466
BANDWIDTH INC(BAND)00036,98731,40713.44%-5,580
BLACKLINE INC(BL)292,0000-292,00014,1470—-14,147
Page 1 of 1
Indaba Capital Management, L.P. — 13F Holdings — Q3 2024 | TickerTrail